Victory Capital Management
IMVT icon

Victory Capital Management’s Immunovant IMVT Stock Holding History

Victory Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
9,361
-253
-3% -$7.71K ﹤0.01% 2131
2026
Q1 		$239K Buy
9,614
+1,077
+13% +$27.9K ﹤0.01% 2165
2025
Q4 		$217K Buy
+8,537
New +$190K ﹤0.01% 2186
2025
Q3 		– Sell
-31,507
Closed -$504K – 2480
2025
Q2 		$504K Buy
+31,507
New +$476K ﹤0.01% 2058
2025
Q1 		– Sell
-45,100
Closed -$1.12M – 2501
2024
Q4 		$1.12M Sell
45,100
-290,260
-87% -$8.23M ﹤0.01% 1757
2024
Q3 		$9.56M Buy
335,360
+22,990
+7% +$678K 0.01% 1120
2024
Q2 		$8.25M Sell
312,370
-6,631
-2% -$189K 0.01% 1132
2024
Q1 		$10.3M Sell
319,001
-6,533
-2% -$238K 0.01% 1056
2023
Q4 		$13.7M Sell
325,534
-47,237
-13% -$1.74M 0.01% 921
2023
Q3 		$14.3M Sell
372,771
-205,364
-36% -$4.64M 0.02% 882
2023
Q2 		$11M Sell
578,135
-87,650
-13% -$1.63M 0.01% 1007
2023
Q1 		$10.3M Buy
+665,785
New +$11.6M 0.01% 1017
2021
Q1 		– Sell
-6,888
Closed -$318K – 2761
2020
Q4 		$318K Buy
6,888
+1,073
+18% +$49.6K ﹤0.01% 2266
2020
Q3 		$205K Buy
+5,815
New +$175K ﹤0.01% 2281

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management's IMVT Position: Q2 2026 in Review

Victory Capital Management reduced its Immunovant (IMVT) stake by 2.6% in Q2 2026, selling an estimated $7.71K and leaving 9,361 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Victory Capital Management first reported a position in IMVT in Q3 2020 and has held it in 14 quarters since. The position peaked at $14.3M in Q3 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Victory Capital Management held 9,361 shares of Immunovant worth $361K as of Q2 2026.
  • Victory Capital Management sold 253 Immunovant shares in Q2 2026, an estimated $7.71K.
  • Immunovant made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2131 holding.
  • Victory Capital Management first reported a position in Immunovant in Q3 2020 and has held it in 14 quarters since.
  • Victory Capital Management's Immunovant position peaked at $14.3M in Q3 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.